The latest news and comment on the National Institute for Health and Care Excellence (Nice)
July 2024
Why testosterone is so important for women during menopause
Letter: Kate Muir takes issue with an article about the use of testosterone by women
June 2024
Blame big pharma, not the NHS, for drug prices
Mounjaro is second obesity drug to be approved for use in England
May 2024
Is systemic racism in medicine putting Black people’s lives at risk?
‘Life-changing’ drug for sickle cell disease to be offered by NHS in England
April 2024
‘Kinder’ treatment for childhood brain cancer to be offered by NHS in England
People with MND in England and Wales fear losing access to life-extending drug
Patients in England to be offered daily pill that can halve migraine frequency
How infective endocarditis deaths among UK dental patients can be avoided
March 2024
Fair Access
South Africans take on big pharma for access to ‘miracle’ cystic fibrosis drug
Cheri Nel cannot afford Vertex’s Trikafta medicine, so she is suing to end ‘patent abuse’ and allow a generic version
‘You don’t want to get better’: the outdated treatment of ME/CFS patients is a national scandal
George Monbiot
The notion that this illness is psychosomatic is having devastating effects, says Guardian columnist George Monbiot
The Price of Life by Jenny Kleeman review – the uncomfortable cost of living
Why disturbing leaks from US gender group WPATH ring alarm bells in the NHS
Hannah Barnes
‘A healthy kid dies and there has been no change’: parents’ anger over lack of warnings for blockbuster asthma drug
February 2024
Drug to treat alopecia recommended for NHS use for first time
Ritlecitinib, taken once a day, approved by Nice for severe hair loss caused by autoimmune disease
January 2024
People severely ill with suspected sepsis should be given antibiotics, Nice says
National Institute for Health and Care Excellence says national early warning score should be used to assess severity of illness
December 2023
Offering CBT for menopause symptoms is about giving women choice
Letter: Paula Briggs and Myra Hunter respond to criticism that the new Nice guidelines for GPs are stigmatising and patronising
I have cystic fibrosis but experts say drugs for others like me are too expensive. What price a life?
Johanna Tate
This medicine comes closer to a cure than any of us could dare to dream of. The planned cut in funding would be a disaster, says Johanna Tate, who works at LSE
New menopause therapy guidance will harm women’s health, say campaigners
Nice guidelines for GPs ‘placing CBT on a par with HRT’ are criticised as ‘patronising’ and ‘scaremongering’
November 2023
Revealed: obesity jab maker discussed targeting benefit claimants with UK government
Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection
About 300 results for National Institute for Health and Care Excellence
